Transcript : Arcturus Therapeutics Holdings Inc. - Special Call

ARCT

Published on 06/30/2025 at 14:05

Presentation Operator MessageOperator (Operator)

Greetings, and welcome to the Arcturus Therapeutics key opinion leader, KOL presentation to discuss ARCT-810 Phase II interim data for OTC deficiency.